NCT03120624 2026-02-04VSV-hIFNbeta-NIS With or Without Ruxolitinib Phosphate in Treating Stage IV or Recurrent Endometrial CancerMayo ClinicPhase 1 Active not recruiting34 enrolled 16 charts
NCT03367741 2025-07-28Cabozantinib S-malate and Nivolumab in Treating Patients With Advanced, Recurrent, or Metastatic Endometrial CancerNational Cancer Institute (NCI)Phase 2 Active not recruiting82 enrolled